4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001628280-26-065566
Senior Vice President, Finance sold 6,000 shares at $36.32 ($217,920)
- Senior Vice President, Finance acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RIKER LAUREN Senior Vice President, Finance | 2026-10-08 | Option exercise 10b5-1 | +6,000 | $32.35 | $194,100 | 68,284.24 | D |
| RIKER LAUREN Senior Vice President, Finance | 2026-10-08 | Sale 10b5-1 | −6,000 | $36.32 | $217,920 | 62,284.24 | D |
| Derivatives | |||||||
| RIKER LAUREN Senior Vice President, Finance | 2026-10-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 0 | D | ||
| Open-market sales · 6,000 sh · avg $36.32 · $217,920 | |||||||
Loading xslF345X06/wk-form4_1791587267.xml…